BDBM306739 BDBM306740::N-(2-(4- ((1R,3R)-2- (2,3-difluoro- propyl)- 3-methyl- 2,3,4,9- tetrahydro-1H- pyrido[3,4- b]indol-1- yl)phenoxy) ethyl)-3- fluoropropan- 1-amine::US10149839, Example 25

SMILES C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1C[C@H](F)CF)c1ccc(OCCNCCCF)cc1

InChI Key InChIKey=XUYQJOXNQQOWGT-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 306739   

TargetEstrogen receptor(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 306739BDBM306739(N-(2-(4- ((1R,3R)-2- (2,3-difluoro- propyl)- 3-met...)
Affinity DataIC50: 1.20nMAssay Description:Compounds were dosed directly from a compound source microplate containing serially diluted compound (4 wells containing 10 mM, 0.1 mM, 1 mM and 10 n...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetEstrogen receptor(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 306739BDBM306739(N-(2-(4- ((1R,3R)-2- (2,3-difluoro- propyl)- 3-met...)
Affinity DataIC50: 2.20nMAssay Description:Compounds were dosed directly from a compound source microplate containing serially diluted compound (4 wells containing 10 mM, 0.1 mM, 1 mM and 10 n...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent